Bone Marrow TransplantationSpeech-Language PathologyBone MarrowTreatment OutcomeTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesRetrospective StudiesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHIV InfectionsRecurrenceCombined Modality TherapyHematopoiesisTime FactorsMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidAcute DiseaseGraft vs Host ReactionImmunosuppressionStem Cell TransplantationLymphocyte DepletionSurvival AnalysisLymphoma, Non-HodgkinHeart TransplantationLeukocyte TransfusionFollow-Up StudiesSevere Combined ImmunodeficiencyT-LymphocytesColony-Forming Units AssayChimeraHLA AntigensMyelodysplastic SyndromesLung TransplantationCyclosporineActuarial AnalysisHematologic DiseasesAntineoplastic Combined Chemotherapy ProtocolsBone DensitySurvival RateLymphocyte TransfusionNuclear FamilyCarmustineOrgan TransplantationPrognosisPancytopeniaCell DifferentiationLeukocyte CountGraft vs Tumor EffectCytarabineGraft vs Leukemia EffectCytomegalovirus InfectionsSpleenMice, Inbred BALB CGranulocyte Colony-Stimulating FactorBone ResorptionMelphalanEtoposideDisease-Free SurvivalProspective StudiesFlow CytometryMultiple MyelomaLymphomaFatal OutcomeCells, CulturedHodgkin DiseasePostoperative ComplicationsAntigens, CD34Mice, Knockout